Protein-modified hyaluronic acid hydrogels to elucidate microenvironment-mediated chemotherapy response in triple negative brain metastatic breast cancer.
Brain metastatic breast cancer (BMBC) remains a major clinical challenge, in part, due to the development of drug resistance. However, the mechanisms associated with response to therapy remain poorly understood. In this work, we developed hyaluronic acid (HA)-based hydrogels functionalized with tunable concentrations o...